MarketPeel
Insider Trading Intelligence
BS

Brent Sabatini

VIR
SVP, CHIEF ACCOUNTING OFFICER · VIR BIOTECHNOLOGY, INC. · CIK 0002037272
FILING MIX · LIFETIME36%/64%
BUYS
4
SELLS
7
TOTAL VALUE
$142.1K
COMPANIES
1
ACTIVE SINCE
Feb 2025
HOLDINGS NOW
61,902
AVG SELL PX
$8.88
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 14 pending
Forward-return performance of every backtestable P/S trade by Brent Sabatini, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+50.00%+0.41%-0.84%+1.24%-0.32%
14d6+33.33%+3.78%-1.85%+5.63%+3.77%
30d6+50.00%+1.64%-2.57%+4.22%+6.37%
60d6+40.00%+1.23%-1.70%+2.92%+5.40%
90d6+50.00%-10.19%+4.19%-24.61%-30.00%
180d6(4 pending)+100.00%-53.09%+7.05%-60.14%-60.14%
1y6(4 pending)+50.00%-10.91%+13.80%-24.70%-24.70%
2y6(6 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VIR · 61,902 shares · as of Jun 1, 2026
018,21836,43654,65472,8722026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2025
2025
2026
2026
FLOW · 4 buys / 7 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
379$9.45$3.6K61,902Jun 1, 2026Jun 2, 2026View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
7,711$9.12$70.3K61,902Mar 23, 2026Mar 24, 2026View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,430$9.53$13.6K69,613Feb 24, 2026Feb 26, 2026View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,829$7.45$13.6K71,043Feb 23, 2026Feb 24, 2026View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
50,00050,000Feb 22, 2026Feb 24, 2026View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
25,00072,872Feb 22, 2026Feb 24, 2026View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,530$7.79$11.9K47,872Feb 13, 2026Feb 18, 2026View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,562$9.45$14.8K46,627Feb 24, 2025Feb 25, 2025View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
20,00048,189Feb 22, 2025Feb 25, 2025View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
40,00040,000Feb 22, 2025Feb 25, 2025View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
1,562$9.15$14.3K28,189Feb 13, 2025Feb 14, 2025View →
Other insiders · VIR
Loading peer insiders…
About this filer
CIK 0002037272
ROLE
SVP, Chief Accounting Officer
PRIMARY
VIR
COMPANIES
1
ACTIVE SINCE
Feb 2025
MARKETPEEL · /INSIDER/0002037272DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback